Illinois legislators recently joined California and New York in proposing bans on several food additives that a growing number of studies have shown to be harmful to human health. Read on for details and comparison of the three state bills and an update on related federal-level activity.
Recent Sanctions Enforcement Actions Demonstrate Importance of Incorporating All Available Data into Screening
For U.S. businesses, sanctions compliance has never been more challenging or more important. The U.S. has responded to Russia’s invasion of Ukraine with a broad range of sanctions targeting the Russian government, its officials, oligarchs and Russia’s financial and energy industries, among others. Indeed, since the invasion of Ukraine, the agency that administers sanctions, the Office of Foreign Assets Control (OFAC), has added over 2500 Russia-related targets to the Specially Designated Nationals and Blocked Persons (SDN) List. These new sanctions mean that there are now more sophisticated and motivated sanctions evaders than ever before. In turn, the U.S. has made clear its determination to pursue those who violate sanctions. As a means of capturing its new level of intensity and commitment to sanctions enforcement, the leadership of the Department of Justice (DOJ) has described sanctions enforcement as “the new FCPA.”[1] Moreover, all of the above was true before Hamas’ attack on Israel and the escalation of violence in the Middle East, which increases the importance of sanctions targeting Hamas, Hezbollah, Iran and other adversaries of the U.S. based in the Middle East.
OIG’s New Compliance Guidance: 10 Action Items and Six Themes for Providers
On Nov. 6, 2023, the U.S. Department of Health and Human Services Office of Inspector General (OIG) issued its General Compliance Program Guidance for healthcare providers and other industry stakeholders. The guidance follows OIG’s previous announcement about a modernization initiative and signifies a major update to OIG’s prior approach to providing guidance on effective compliance…
Corporate Transparency Act: Three Updates for January 2024
RELATED UPDATE: Deputy Attorney General Monaco Announces New DOJ Whistleblower Program (March 8, 2024)
As of January 1, 2024, the Corporate Transparency Act (“CTA”) has gone into effect. Companies that may be Reporting Companies of Beneficial Ownership Information (“BOI”) should be aware of three key aspects of the CTA.
- One, entities formed on or after January 1, 2024 must file, within 90 days after formation or registration, their required BOI with the Financial Crimes Enforcement Network (“FinCEN”). McGuireWoods has published prior alerts on the CTA generally, the use of FinCEN identifiers to report BOI, and FinCEN’s extension of the time to file from 30 to 90 days. As a reminder, Reporting Companies in existence prior to January 1, 2024 have until January 1, 2025 to make their required reports. FinCEN has published guidance materials to facilitate understanding the BOI reporting requirements, which include a Small Business Compliance Guide, FAQs, and other resource materials. These are available on FinCEN’s website. FinCEN plans to continue developing guidance and other materials to ensure timely, accurate, and complete reporting. FinCEN also established a dedicated BOI contact center to respond to questions regarding reporting requirements, as well as to provide technical assistance to users encountering issues with its Beneficial Ownership Secure System (“BOSS”).
- Two, FinCEN met its January 1, 2024 deadline to have the BOSS up and running to receive, store, and maintain BOI.
- Three, FinCEN adopted a new regulation that addresses how FinCEN will regulate access to the BOI reported to FinCEN. While the new access rule takes effect on February 20, 2024, access will be phased in over time to ensure that the proper controls are in place to, among other things, ensure the security of the reported information.
A Failed Constitutional Challenge to the AKS Safe Harbor Provision – More to come?
This past summer, in United States v. Booker, a North Carolina district court ruled against a challenge to the constitutionality of Congress’s delegation of authority to promulgate safe harbors to the Anti-Kickback Statute (AKS). In filing a motion for acquittal, Defendant Donald Booker argued the AKS “Safe Harbor Provision,” which grants the Secretary of Health and Human Services (HHS) the authority to exempt certain conduct from the “illegal remuneration” prohibitions of the AKS, violates the nondelegation doctrine. While Booker’s argument may appear paradoxical as, if successful, he would be prosecuted under the AKS without the protection of this safe harbor, the case raises an interesting example of a constitutional challenge to the AKS, which we may see more to come directly or with the FCA in the new year.
FTC Issues Largest Fine in Made in USA Enforcement — but Seeks to Collect Much Less
On Dec. 6, the Federal Trade Commission issued a proposed order against ExotoUSA LLC and its owner to resolve allegations that they improperly marketed products online using unqualified Made in USA claims and other false or misleading claims. Read on for details about this case and takeaways for companies that label and market their products…
The Growing Causal Divide: But-For Causation in AKS/FCA Actions
In United States v. Regeneron, the District of Massachusetts Court recently joined the Sixth and Eighth Circuits in requiring the government to show a direct tie between kickbacks and referrals that proximately caused claims to federal healthcare programs to prevail in Anti-Kickback Statute (AKS) and False Claims Act (FCA) actions. The District Court’s ruling contributes to the growing split between the Third Circuit, which requires a mere causal connection between kickbacks and referrals, and the Sixth and Eighth Circuits, which require but-for causation between the kickback and the federal claim. This split relates to the per se fraud clause added to the AKS in 2010, which provides “a claim that includes items or services resulting from a violation of this section constitutes a false or fraudulent claim” for purposes of the FCA. The specific causal connotation of the language “resulting from” is the core of the debate between circuits.
Up-and-Coming Women in PE to Know: Michelle Fang Jordan
McGuireWoods has long been an avid supporter of the advancement of professional women. As part of our initiative seeking to expand the leadership of women in private equity, we are continuing our series of profiling women leaders in private equity. We are hopeful that this series will serve to inspire other women to pursue their…
Homeland Security and HHS Release Interactive Healthcare Cybersecurity Toolkit
In light of a significant rise in cyberattacks against hospitals and health systems, the U.S. Department of Homeland Security Cybersecurity and Infrastructure Security Agency and the U.S. Department of Health and Human Services recently released a cybersecurity toolkit. Read on for details about the toolkit and how the federal government is prioritizing cybersecurity in healthcare.…
HHS Rescheduling, SAFER Banking Act May Change the Marijuana Landscape
In late August, the Department of Health and Human Services recommended rescheduling marijuana from a Schedule I substance to a Schedule III substance under the Controlled Substance Act. Meanwhile Congress is weighing a bill that would create federal safe harbors for financial institutions to accept deposits from state-sanctioned marijuana business operators. Read on for details…